According to Sesen Bio
's latest financial reports the company has $0.16 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2021-12-31 | $0.16 B | 210.44% |
2020-12-31 | $52.38 M | 8.87% |
2019-12-31 | $48.12 M | -4.56% |
2018-12-31 | $50.42 M | 243.47% |
2017-12-31 | $14.68 M | -42.07% |
2016-12-31 | $25.34 M | -29.76% |
2015-12-31 | $36.07 M | -33.26% |
2014-12-31 | $54.05 M | 580.67% |
2013-12-31 | $7.94 M | 0.76% |
2012-12-31 | $7.88 M | 1026% |
2011-12-31 | $0.7 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 24.72% | ๐บ๐ธ USA |